Ivo Lorenz

5 Patents

• US124417892025

  Dll3-targeting Antibodies and Uses Thereof

  Tri-institutional Therapeutics Discovery Institute

  0 cites
• US122811742025

  High-affinity Anti-mertk Antibodies and Uses Thereof

  Inspirna, Inc.

  0 cites
• US122410972025

  Compositions and Methods for Adoptive Cell Therapy for Cancer

  Memorial Sloan Kettering Cancer Center

  0 cites
• US118914162024

  Recombinant Viral Vectors

  INTERNATIONAL AIDS VACCINE INITIATIVE, Inc.

  0 cites
• US117952192023

  Antibody Molecules for Cancer Treatment

  Boehringer Ingelheim International GmbH

  0 cites